Grant Stuart 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Jun 4, 2010
Insider Transaction Report
Form 4
Grant Stuart
SR VP & CFO
Transactions
- Sale
Common Stock
2010-06-03$6.97/sh−1,250$8,713→ 11,717 total - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2010-06-03−1,250→ 106,251 totalExercise: $1.20From: 2010-03-02Exp: 2019-03-02→ Common Stock (1,250 underlying) - Exercise/Conversion
Common Stock
2010-06-03$1.20/sh+1,250$1,500→ 12,967 total
Footnotes (1)
- [F1]Transacted under a 10b5-1 plan that was adopted on 11/23/2009.